HCA said it had announced in its Original 8-K filed on January 30, 2024 the appointment of Michael A. Marks as Executive Vice President and Chief Financial Officer, effective May 1, 2024.

1. 01

   HCA said it had announced in its Original 8-K filed on January 30, 2024 the appointment of Michael A. Marks as Executive Vice President and Chief Financial Officer, effective May 1, 2024.

2. 02

   The company said it filed Amendment No. 1 to provide information on changes to Mr. Marks' compensation arrangements that had not been determined when the Original 8-K was filed, and that the changes were approved by the Compensation Committee of the Board on February 22, 2024.

3. 03

   HCA adopted the Executive Officer Performance Excellence Program on February 22, 2024, and said Marks' performance award opportunity is weighted 80% on EBITDA target achievement and 20% on quality metric target achievement.

4. 04

   The company said Marks' 2024 Executive Officer PEP award opportunity is initially set at 65% of base salary and will increase to 110% of base salary effective May 1, 2024.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.